Transparency Market Research Albumin (Excipient) Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 - 2020
Published Date 2015-01-14
87 Page Report
Buy Now
Request Sample
Press Release
Albumin (Excipient) Market Expected to Reach USD 0.8 Billion Globally in 2020 Transparency Market Research State Tower, 90, State Street, Suite 700. Albany, NY 12207 United States www.transparencymarketresearch.com sales@transparencymarketresearch.com
Albumin (Excipient) Market
REPORT DESCRIPTION
Albumin (Excipient) Market- Global Industry Analysis, Size, Volume and Forecast 2014-2020
According to a new market report published by Transparency Market Research “Albumin (Excipient) Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast, 2014 - 2020,� the global albumin excipient market was valued at USD 704.9 million in 2013 and is expected to grow at a CAGR of 2.3% from 2014 to 2020, to reach an estimated value of USD 828.2 million by 2020.
Selection of appropriate excipients is very important during the development of drug formulations and vaccines. A suitable excipient helps stabilize and protect an active pharmaceutical ingredient (API) in the formulation against degradation, oxidation or aggregation that the API could undergo during manufacturing, transport and storage. As an excipient, albumin has wide applications in drug formulation, drug delivery, vaccine manufacturing and as a component of media for the production of vaccines. Manufacturers are increasingly considering innovative ways to reduce contamination risks of finished products due to the recent incidents of animal virus contamination of biopharmaceutical products. Manufacturers must adhere to strict regulations on the standards and also provide detailed information on the country of origin (BSE free), the types of tissue used and details of the manufacturing process during the compliance and approval procedure.
Browse the full Albumin (Excipient) Market Report at : http://www.transparencymarketresearch.com/albumin-market.html
The global albumin market is analyzed by albumin type, applications and geography. On the basis of type, the market is segmented into human serum albumin, bovine serum albumin and recombinant albumin. Human serum albumin was the largest segment and was valued at USD 476.7 million in 2013. The segment is expected to reach USD 557.0 million in 2020, growing at a CAGR of 2.2% during the forecast period between 2014 and 2020. Bovine serum albumin is used in the production of vaccines such as MMR II, Varivax, Zostavax and RotaTeq in ranges of less than 1 ppm. Extensive research to explore new ways is underway to increase virus yield and
Transparency Market Research
2
Albumin (Excipient) Market
quality in manufacturing. Recently, end-user preference has been observed to have shifted towards recombinant human albumin (rAlbumin) used in multiple applications such as in nano formulation and drug carrier over specific therapeutic modalities. Advances in yeast-based protein expression and the successful scale-up have led to the development of an industrial-scale manufacturing process that can produce a highly pure, animal-free rAlbumin suitable for use as an excipient in biotherapeutics.
Get Free Sample Report Albumin (Excipient) Market : http://www.transparencymarketresearch.com/sample/sample.php? flag=S&rep_id=3984
Primary applications of albumin include drug formulation and drug delivery, vaccines, and component of media. The drug formulation and drug delivery segment is expected to reach USD 395.9 million in 2020. Expansion of the role of albumin in drug delivery has widened the field of nanotechnology as well. For instance, Abraxis BioScience has applied nanotechnology to human serum albumin (HSA) with its nanoparticle albumin-bound, known as ‘NAB’ technology platform. This approach combines HSA with an API for delivering protein drugs.
Geographically, North America continues to dominate the market due to high demand for albumin in drug formulations, and research and development activities. The albumin market in the region was valued at USD 253.8 million in 2013. The current focus of the research community in most of the academic institutions and industry is to use albumin as a carrier for micro- and nanoparticles for sustained-release injectable drugs. Paclitaxel nano-particulate formulation containing albumin as a carrier was approved by the U.S. FDA in September 2013. Countries such as China, India and Australia exhibit significant growth prospects in terms of rapid increase in the research collaboration between industry and research institutions. GlaxoSmithKline Pharmaceuticals Limited (GSK) is funding around USD 4 million per year to initiate research and development program with the leading research institutions in Asia Pacific for the development of potential therapeutics.
Browse the full Albumin (Excipient) Market press release at :
Transparency Market Research
3
Albumin (Excipient) Market
http://www.transparencymarketresearch.com/pressrelease/albuminmarket.htm
Some of the major companies operating in the global albumin market are CSL Behring, HiMedia, InVitria, Mitsubishi Tanabe Pharma, Octapharma AG, Novozymes A/S, Raybiotech, Inc., SigmaAldrich Corporation, Thermo Fischer Scientific, Inc. and MedxBio Pte. Ltd. Pharmaceutical companies and research institutes obtain the desired albumin excipient grade from the market players for their development activities. The key players in the global albumin market improve their distribution network by entering into strategic alliances and distributorship agreements. For instance, InVitria partnered with Thermo Fischer Scientific and Sigma-Aldrich in order to provide its customers with product support best tailored to meet their needs. InVitria has distributors across the world including North America, Europe, Asia and Australia.
The global albumin market is segmented as follows:
Albumin Market Revenue (USD Million), by Type
➢ Human Serum Albumin
➢ Bovine Serum Albumin
➢ Recombinant Albumin
Albumin Market Revenue (USD Million) and Volume (kg), by Application
➢ Drug Formulation and Drug Delivery
Transparency Market Research
4
Albumin (Excipient) Market
➢ Vaccines
➢ Component of Medium
Albumin Market Revenue (USD Million) and Volume (kg), by Geography
➢ North America
➢ Europe
➢ Asia Pacific
➢ Rest of the World
TABLE OF CONTENT
Chapter 1 Preface 1.1 Report Description 1.2 Market Segmentation 1.3 Research Methodology 1.3.1 Sources 1.3.1.1 Secondary Research
Transparency Market Research
5
Albumin (Excipient) Market
1.3.1.2 Primary Research 1.3.2 Assumptions and Limitations 1.4 List of Abbreviations
Chapter 2 Executive Summary 2.1 Market Snapshot: Global Albumin Market (2013 & 2020) 2.2 Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 & 2020 (Value %) 2.3 Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)
Chapter 3 Albumin Market Overview 3.1 Introduction 3.2 Market Dynamics 3.2.1 Drivers 3.2.1.1 Improved product stability with albumin as an excipient leading to increase in demand 3.2.1.2 Improvements in protein purification and molecular separation technology to boost market growth 3.2.1.3 Use of recombinant albumin to drive the albumin market 3.2.2 Restraints 3.2.2.1 Stringent regulations, cost and health care issues are anticipated to affect the market 3.2.2.2 Trend toward serum-free, specialty and customized media solutions could hamper the albumin market
Transparency Market Research
6
Albumin (Excipient) Market
3.2.3 Opportunities 3.2.3.1 Expanding applications of albumin such as nanotechnology would revolutionize the albumin market, particularly recombinant albumin 3.2.3.2 Focus on emerging regions to provide immense potential for the global albumin market 3.3 Porter’s Five Force Analysis for the Global Albumin Market 3.3.1 Bargaining Power of Suppliers 3.3.2 Bargaining Power of Buyers 3.3.3 Threat of Substitutes 3.3.4 Threat of New Entrants 3.3.5 Competitive Rivalry 3.4 Market Attractiveness Analysis: Global Albumin Market, by Geography, 2013 3.5 Event Impact Analysis 3.6 Clinical Pipeline Analysis
Chapter 4 Global Albumin Market Revenue (USD Million), by Type, 2012 – 2020 4.1 Introduction 4.1.1 Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million) 4.1.2 Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 & 2020 (Value %) 4.1.3 Price Range for Each Albumin Type 4.2 Human Serum Albumin (HSA) 4.2.1 Global HSA Market Revenue, 2012 – 2020 (USD Million)
Transparency Market Research
7
Albumin (Excipient) Market
4.3 Bovine Serum Albumin (BSA) 4.3.1 Global BSA Market Revenue, 2012 – 2020 (USD Million) 4.4 Recombinant Albumin (rAlbumin) 4.4.1 Global rAlbumin Market Revenue, 2012 – 2020 (USD Million)
Chapter 5 Global Albumin Market Revenue (USD Million) and Volume (kg), by Application, 2012 – 2020 5.1 Introduction 5.1.1 Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million) 5.1.2 Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 & 2020 (Value %) 5.2 Drug Formulation and Drug Delivery 5.2.1 Global Drug Formulation and Drug Delivery Market Revenue, 2012 – 2020 (USD Million) 5.2.2 Global Drug Formulation and Drug Delivery Market Volume, 2012 – 2020 (kilograms) 5.3 Vaccines 5.3.1 Global Vaccines Market Revenue, 2012 – 2020 (USD Million) 5.3.2 Global Vaccines Market Volume, 2012 – 2020 (kilograms) 5.4 Component of Media 5.4.1 Global Component of Media Market Revenue, 2012 – 2020 (USD Million) 5.4.2 Global Component of Media Market Volume, 2012 – 2020 (kilograms)
Chapter 6 Global Albumin Market Revenue (USD Million) & Volume (kg), by Geography, 2012 – 2020 6.1 Overview
Transparency Market Research
8
Albumin (Excipient) Market
6.1.1 Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million) 6.1.2 Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms) 6.2 North America 6.2.1 North America Albumin Market Revenue, 2012 – 2020, (USD Million) 6.2.2 North America Albumin Market Volume, 2012 – 2020, (kilograms) 6.3 Europe 6.3.1 Europe Albumin Market Revenue, 2012 – 2020 (USD Million) 6.3.2 Europe Albumin Market Volume, 2012 – 2020 (kilograms) 6.4 Asia Pacific 6.4.1 Asia Pacific Albumin Market Revenue, 2012 – 2020 (USD Million) 6.4.2 Asia Pacific Albumin Market Volume, 2012 – 2020 (kilograms) 6.5 Rest of the World (RoW) 6.5.1 Rest of the World Albumin Market Revenue, 2012 – 2020 (USD Million) 6.5.2 Rest of the World Albumin Market Volume, 2012 – 2020 (kilograms)
Chapter 7 Recommendations 7.1 Marketing Strategies for Success 7.2 Barriers to be Considered
Chapter 8 Company Profiles 8.1 CSL Behring LLC
Transparency Market Research
9
Albumin (Excipient) Market
8.1.1 Company Overview 8.1.2 Financial Overview 8.1.3 Product Portfolio 8.1.4 Business Strategies 8.1.5 Recent Developments 8.2 HiMedia Laboratories 8.2.1 Company Overview 8.2.2 Financial Overview 8.2.3 Product Portfolio 8.2.4 Business Strategies 8.2.5 Recent Developments 8.3 InVitria (Ventria Bioscience) 8.3.1 Company Overview 8.3.2 Financial Overview 8.3.3 Product Portfolio 8.3.4 Business Strategies 8.3.5 Recent Developments 8.4 MedxBio Pte. Ltd. 8.4.1 Company Overview 8.4.2 Financial Overview 8.4.3 Product Portfolio
Transparency Market Research
10
Albumin (Excipient) Market
8.4.4 Business Strategies 8.5 Mitsubishi Tanabe Pharma 8.5.1 Company Overview 8.5.2 Financial Overview 8.5.3 Product Portfolio 8.5.4 Business Strategies 8.5.5 Recent Developments 8.6 Novozymes A/S 8.6.1 Company Overview 8.6.2 Financial Overview 8.6.3 Product Portfolio 8.6.4 Business Strategies 8.6.5 Recent Developments 8.7 Octapharma AG 8.7.1 Company Overview 8.7.2 Financial Overview 8.7.3 Product Portfolio 8.7.4 Business Strategies 8.7.5 Recent Developments 8.8 RayBiotech, Inc. 8.8.1 Company Overview:
Transparency Market Research
11
Albumin (Excipient) Market
8.8.2 Financial Overview 8.8.3 Product Portfolio 8.8.4 Business Strategies 8.8.5 Recent Developments 8.9 Sigma-Aldrich Corporation 8.9.1 Company Overview 8.9.2 Financial Overview 8.9.3 Product Portfolio 8.9.4 Business Strategies 8.9.5 Recent Developments 8.10 Thermo Fisher Scientific 8.10.1 Company Overview 8.10.2 Financial Overview 8.10.3 Product Portfolio 8.10.4 Business Strategies 8.10.5 Recent Developments List of Figures
FIG. 1 Market Segmentation: Global Albumin Market FIG. 2 Comparative Analysis: Global Albumin Market Revenue, by Geography, 2013 &2020 (Value %) FIG. 3 Global Albumin Market Volume, by Geography, 2012 - 2020 (Kilograms)
Transparency Market Research
12
Albumin (Excipient) Market
FIG. 4 Porter’s Five Forces Analysis: Global Albumin Market FIG. 5 Market Attractiveness Analysis: Global Albumin Market, by Geography, 2013 FIG. 6 Comparative Analysis: Global Albumin Market Revenue, by Type, 2013 &2020 (Value %) FIG. 7 Global HSA Market Revenue, 2012 – 2020 (USD Million) FIG. 8 Global BSA Market Revenue, 2012 – 2020 (USD Million) FIG. 9 Global rAlbumin Market Revenue, 2012 – 2020 (USD Million) FIG. 10 Comparative Analysis: Global Albumin Market Revenue, by Application, 2013 &2020 (Value %) FIG. 11 Global Drug Formulation and Drug Delivery Market Revenue, 2012 – 2020 (USD Million) FIG. 12 Global Drug Formulation and Drug Delivery Market Volume, 2012 – 2020 (kilograms) FIG. 13 Global Vaccines Market Revenue, 2012 – 2020 (USD Million) FIG. 14 Global Vaccines Market Volume, 2012 – 2020 (kilograms) FIG. 15 Global Component of Media Market Revenue, 2012 – 2020 (USD Million) FIG. 16 Global Component of Media Market Volume, 2012 – 2020 (kilograms) FIG. 17 North America Albumin Market Revenue, 2012 – 2020 (USD Million) FIG. 18 North America Albumin Market Volume, 2012 – 2020 (kilograms) FIG. 19 Europe Albumin Market Revenue, 2012 – 2020 (USD Million) FIG. 20 Europe Albumin Market Volume, 2012 – 2020 (kilograms) FIG. 21 Asia Pacific Albumin Market Revenue, 2012 – 2020 (USD Million) FIG. 22 Asia Pacific Albumin Market Volume, 2012 – 2020 (kilograms) FIG. 23 Rest of the World Albumin Market Revenue, 2012 – 2020 (USD Million) FIG. 24 Rest of the World Albumin Market Volume, 2012 – 2020 (kilograms)
Transparency Market Research
13
Albumin (Excipient) Market
FIG. 25 CSL Behring, Inc.: Annual Revenue, 2011 – 2013 (USD Million) FIG. 26 Mitsubishi Tanabe Pharma: Annual Revenue, 2011 – 2013 (USD Million) FIG. 27 Novozymes: Annual Revenue, 2011 – 2013 (USD Million) FIG. 28 Octapharma AG: Annual Revenue, 2011 – 2013 (USD Million) FIG. 29 Sigma-Aldrich Corporation: Annual Revenue, 2011 – 2013 (USD Million) FIG. 30 Thermo Fisher Scientific: Annual Revenue, 2011 – 2013 (USD Million) List of Tables TABLE 1 List of Abbreviations TABLE 2 Market Snapshot: Global Albumin Market (2013 & 2020) TABLE 3 Event Impact Analysis: Global Albumin Market TABLE 4 Ongoing Clinical Trials with Albumin as an Excipient TABLE 5 Global Albumin Market Revenue, by Type, 2012 - 2020 (USD Million) TABLE 6 Price Range for Each Albumin Type (USD/ kg) TABLE 7 Global Albumin Market Revenue, by Application, 2012 - 2020 (USD Million) TABLE 8 Global Albumin Market Revenue, by Geography, 2012 - 2020 (USD Million) TABLE 9 Global Albumin Market Volume, by Geography, 2012 - 2020 (kilograms) Browse All Pharmaceutical Market Research Reports @ http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html
About Us
Transparency Market Research
14
Albumin (Excipient) Market
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forwardlooking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/ Browse The Market Research Blog : http://researchandreports.wordpress.com/ http://www.transparencymarketresearch.com
Transparency Market Research
15